{"DataElement":{"publicId":"6270564","version":"1","preferredName":"Intestinal Tubular Adenocarcinoma Subclass Category","preferredDefinition":"Text term that represents the histologic sub-classification category for tubular (intestinal) adenocarcinoma.","longName":"tubular_adenocarcinoma_subclas","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6270515","version":"1","preferredName":"Intestinal Tubular Adenocarcinoma Subclass","preferredDefinition":"Of, or related to, or referring to the intestines._An infiltrating adenocarcinoma in which the malignant cells form tubular structures. Representative examples include the tubular breast carcinoma and the gastric tubular adenocarcinoma._A taxonomic subdivisions more specific than class but more general than order.","longName":"6270512v1.0:6270513v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6270512","version":"1","preferredName":"Intestinal Tubular Adenocarcinoma","preferredDefinition":"Of, or related to, or referring to the intestines.:An infiltrating adenocarcinoma in which the malignant cells form tubular structures. Representative examples include the tubular breast carcinoma and the gastric tubular adenocarcinoma.","longName":"C25266:C65192","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal","conceptCode":"C25266","definition":"Of, or related to, or referring to the intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tubular Adenocarcinoma","conceptCode":"C65192","definition":"An infiltrating adenocarcinoma in which the malignant cells form tubular structures. Representative examples include the tubular breast carcinoma and the gastric tubular adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA5145E-9CE1-5352-E053-F662850A1890","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6270513","version":"1","preferredName":"Subclass","preferredDefinition":"A taxonomic subdivisions more specific than class but more general than order.","longName":"C45285","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subclass","conceptCode":"C45285","definition":"A taxonomic subdivisions more specific than class but more general than order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA5145E-9CEF-5352-E053-F662850A1890","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA5145E-9D00-5352-E053-F662850A1890","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeDescription":"Created for Stomach cancer request 4.19.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6270539","version":"1","preferredName":"Tubular Adenocarcinoma Subclass Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"6270539v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mixed carcinoma","valueDescription":"Mixed Carcinoma","ValueMeaning":{"publicId":"4264923","version":"1","preferredName":"Mixed Carcinoma","longName":"4264923","preferredDefinition":"Involving or composed of different kinds.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67FEF75-9FE5-6988-E040-BB89AD432041","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-522E-51DD-E053-F662850A1C65","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"},{"value":"Papillary adenocarcinoma","valueDescription":"Papillary Adenocarcinoma","ValueMeaning":{"publicId":"3251702","version":"1","preferredName":"Papillary Adenocarcinoma","longName":"3251702","preferredDefinition":"A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Adenocarcinoma","conceptCode":"C2853","definition":"A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D53F-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-5238-51DD-E053-F662850A1C65","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"},{"value":"Mucinous adenocarcinoma (>50% mucinous)","valueDescription":"Greater Than Fifty Percent Unit Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"6270540","version":"1","preferredName":"Greater Than Fifty Percent Unit Mucinous Adenocarcinoma","longName":"6270540","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).: An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Fifty","conceptCode":"C105785","definition":"A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA54529-5247-51DD-E053-F662850A1C65","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-5260-51DD-E053-F662850A1C65","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"},{"value":"Poorly cohesive carcinoma (including signet-ring cell carcinoma and other variants)","valueDescription":"Poorly Cohesive Gastric Carcinoma","ValueMeaning":{"publicId":"3725260","version":"1","preferredName":"Poorly Cohesive Gastric Carcinoma","longName":"3725260","preferredDefinition":"An adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates.  This category includes signet ring cell adenocarcinomas, adenocarcinomas that are composed of malignant cells resembling lymphocytes and histiocytes, and adenocarcinomas that are composed of malignant cells with deeply eosinophilic cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Poorly Cohesive Adenocarcinoma","conceptCode":"C95743","definition":"An adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates.  This category includes signet ring cell adenocarcinomas, adenocarcinomas that are composed of malignant cells resembling lymphocytes and histiocytes, and adenocarcinomas that are composed of malignant cells with deeply eosinophilic cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA2D77B4-6140-D69C-E040-BB89AD430B15","latestVersionIndicator":"Yes","beginDate":"2013-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-5274-51DD-E053-F662850A1C65","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"},{"value":"Not determined","valueDescription":"Undetermined","ValueMeaning":{"publicId":"5751657","version":"1","preferredName":"Undetermined","longName":"5751657","preferredDefinition":"A term referring to the lack of definitive criteria for classification of a finding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undetermined","conceptCode":"C124294","definition":"A term referring to the lack of definitive criteria for classification of a finding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CF93515-1275-3240-E053-F662850A2834","latestVersionIndicator":"Yes","beginDate":"2017-04-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-04-12","modifiedBy":"MAESKEB","dateModified":"2018-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-527F-51DD-E053-F662850A1C65","beginDate":"2017-10-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-5289-51DD-E053-F662850A1C65","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA54529-5293-51DD-E053-F662850A1C65","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA54529-5216-51DD-E053-F662850A1C65","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeDescription":"Created for Stomach cancer request 4.19.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000437","version":"1","longName":"Stomach","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If tubular (intestinal) adeno","type":"Preferred Question Text","description":"If tubular (intestinal) adenocarcinoma, what is the subclassification?","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA56724-D4DF-6756-E053-F662850A2DE3","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeDescription":"Created for Stomach cancer request 4.19.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}